Reuters: Regulatory News: EU agency recommends Sanofi, Merck paediatric vaccine

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

EU agency recommends Sanofi, Merck paediatric vaccine Feb 22nd 2013, 12:10 LONDON | Fri Feb 22, 2013 7:10am EST LONDON Feb 22 (Reuters) - The European Medicines Agency recommended approval of Hexyon, a new 6-in-1 paediatric vaccine from Sanofi Pasteur MSD, a joint venture between Merck and Sanofi, the companies said on Friday. The new vaccine protects against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis and invasive infections caused by Haemophilus influenzae type b. Recommendations for marketing approval by the EMA's Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions